JAK2 and myeloproliferative disorder: JAK2 mutation-prevalent myeloproliferative neoplasms (MPN) include primary myelofibrosis (PMF), polycythemia vera (PV), essential thrombocythemia (ET), and MPN, unclassifiable (MPN-U) [1, 2].